Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: Systematic review

Palliative Medicine

Volumn 25, Issue 5, 2011, Pages 553-559

  Bennett, Michael I ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Adjuvant drugs; cancer pain; neuropathic pain; opioids

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPRENORPHINE; FENTANYL; GABAPENTIN; IMIPRAMINE; MORPHINE; OPIATE; PHENYTOIN; PLACEBO; TRAMADOL; VALPROIC ACID;

ANALGESIA; CANCER PAIN; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONFUSION; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; HUMAN; MONOTHERAPY; NEUROPATHIC PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RESPIRATION DEPRESSION; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ANALGESICS, OPIOID; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 79959882753     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216310378546     Document Type: Conference Paper

References (22)

1. Grond S, Radbruch L, Meuser T, et al. Assessment and treatment of neuropathic cancer patients following WHO guidelines. Pain. 1999 ; 79: 15-20 (Pubitemid 29012430)
2. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. Pain. 1999 ; 82: 263-274 (Pubitemid 29369094)
3. Freynhagen RJ, Bennett MI. Diagnosis and management of neuropathic pain (Clinical Review). Br Med J. 2009 ; 339: 391-395
4. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005 ; 96: 399-409 (Pubitemid 40835693)
5. Wang GK, Russell C, Wang SY. State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain. Pain. 2004 ; 110: 166-174 (Pubitemid 38953280)
6. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug gabapentin binds to the α2δ subunit of a calcium channel. J Biol Chem. 1996 ; 271: 5768-5776 (Pubitemid 26083915)
7. Shimoyama M, Shimoyama N, Hori Y. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain. 2000 ; 85: 405-414 (Pubitemid 30214167)
8. Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol. 1984 ; 7: 51-82 (Pubitemid 14138568)
9. Berger A, Dukes E, Mercadante S, Oster G. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care. 2006 ; 15: 138-145 (Pubitemid 43542755)
10. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: A randomized open trial. J Pain Symptom Manag. 2007 ; 34: 183-189 (Pubitemid 47088905)
11. Caraceni A, Zecca E, Bonezzi C, Arcuri E, Tur RY, Maltoni M, et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group. J Clinical Oncol. 2004 ; 22: 2909-2917 (Pubitemid 41079911)
12. Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori. 2002 ; 88: 239-242 (Pubitemid 34875452)
13. Yajnik S, Singh GP, Singh G, Kumar M. Phenytoin as a coanalgesic in cancer pain. J Pain Symptom Manag. 1992 ; 7: 209-213
14. Walsh TD. Controlled study of imipramine and morphine in chronic pain due to advanced cancer (published abstract). Proceedings of ASCO. 1986 ;: 237-237
15. Ross JR, Goller K, Hardy J, Riley J, Broadley K, A'hern R, et al. Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study. J Palliat Med. 2005 ; 8: 1118-1126 (Pubitemid 43010543)
16. Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manag. 1999 ; 17: 441-445 (Pubitemid 29289771)
17. Hardy JR, Rees EAJ, Gwilliam B, Ling J, Broadley K, A'hern R. A phase ii study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manag. 2001 ; 21: 204-209 (Pubitemid 32194417)
18. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005 ; 352: 1324-1334 (Pubitemid 40411499)
19. Bennett MI. Gabapentin significantly improves analgesia in people receiving opioids for neuropathic cancer pain. Canc Treat Rev. 2005 ; 31: 58-62 (Pubitemid 40246992)
20. Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009 ; 20: 1420-1433
21. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007 ; 18: 1437-1449 (Pubitemid 47365475)
22. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009 ; 374: 1252-1261